Loading...
Anika Therapeutics, Inc.
ANIK•NASDAQ
Healthcare
Medical - Devices
$11.50
$0.19(1.68%)
Anika Therapeutics, Inc. (ANIK) Financial Performance & Income Statement Overview
Review Anika Therapeutics, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-28.05%
↓ 28.05%
Operating Income Growth
94.18%
↑ 94.18%
Net Income Growth
31.79%
↑ 31.79%
Operating Cash Flow Growth
402.18%
↑ 402.18%
Operating Margin
-4.09%
↓ 4.09%
Gross Margin
62.58%
↑ 62.58%
Net Profit Margin
-53.76%
↓ 53.76%
ROE
-32.77%
↓ 32.77%
ROIC
-2.50%
↓ 2.50%
Anika Therapeutics, Inc. (ANIK) Income Statement & Financial Overview
Review Anika Therapeutics, Inc.'s (ANIK) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | -$1.29M | $38.75M | $41.92M | $40.52M |
| Cost of Revenue | -$23.86M | $37.31M | $14.56M | $15.89M |
| Gross Profit | $22.57M | $1.44M | $27.36M | $24.63M |
| Gross Profit Ratio | -$17.49 | $0.04 | $0.65 | $0.61 |
| R&D Expenses | $2.74M | $7.24M | $7.40M | $8.16M |
| SG&A Expenses | -$4.89M | $19.11M | $19.81M | $21.53M |
| Operating Expenses | -$5.25M | $29.46M | $27.20M | $29.69M |
| Total Costs & Expenses | -$29.11M | $66.77M | $41.76M | $45.59M |
| Interest Income | $0.00 | $406000.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $592000.00 |
| Depreciation & Amortization | $1.81M | $2.19M | $2.06M | $2.60M |
| EBITDA | $26.53M | -$25.42M | $2.22M | -$1.87M |
| EBITDA Ratio | -$20.57 | -$0.66 | $0.05 | -$0.05 |
| Operating Income | $27.82M | -$28.02M | $161000.00 | -$5.06M |
| Operating Income Ratio | -$21.56 | -$0.72 | $0.004 | -$0.12 |
| Other Income/Expenses (Net) | $744000.00 | $406000.00 | $595000.00 | $592000.00 |
| Income Before Tax | $28.56M | -$27.61M | $756000.00 | -$4.47M |
| Income Before Tax Ratio | -$22.14 | -$0.71 | $0.02 | -$0.11 |
| Income Tax Expense | $2.87M | $2.31M | $844000.00 | $43000.00 |
| Net Income | -$21.86M | -$29.92M | -$88000.00 | -$4.51M |
| Net Income Ratio | $16.95 | -$0.77 | -$0.002 | -$0.11 |
| EPS | -$1.49 | -$2.03 | -$0.006 | -$0.31 |
| Diluted EPS | -$1.49 | -$2.03 | -$0.006 | -$0.31 |
| Weighted Avg Shares Outstanding | $14.58M | $14.77M | $14.84M | $14.70M |
| Weighted Avg Shares Outstanding (Diluted) | $14.58M | $14.77M | $14.84M | $14.70M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan